Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
- 31 October 2009
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 52 (2), 126-140
- https://doi.org/10.1016/j.pcad.2009.06.004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patientsAtherosclerosis, 2009
- Resistin, Adiponectin, and Risk of Heart FailureJournal of the American College of Cardiology, 2008
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic InterventionsJournal of the American College of Cardiology, 2005
- Implications of plasma concentrations of adiponectin in patients with coronary artery diseaseHeart, 2004
- Expression of adiponectin receptors in pancreatic β cellsBiochemical and Biophysical Research Communications, 2003
- A calcium channel blocker activates both ecto-5′-nucleotidase and NO synthase in HUVECBiochemical and Biophysical Research Communications, 2003
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- Hormonal Regulation of Adiponectin Gene Expression in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 2002